Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Category
Equity - Leveraged / Inverse
Sponsor
Corgi Strategies
Fund Family
Index
-
Index Weighting
Active/Passive
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Expense
0.45%
Inverse/Leveraged
IPO
Jun 03, 2026
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
No / No
Tags
Tags
Tags
Tags
Tags
Tags
-
Tags
-
Sector/Theme
Region
SMA20
9.58%
SMA50
12.88%
SMA200
12.88%
Return% 1Y
-
Return% 3Y
-
Return% 5Y
-
Return% 10Y
Return% SI
Flows% 1M
0.00%
Flows% 3M
43.85%
Flows% YTD
43.85%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
2
AUM
738.72K
NAV/sh
52W High
41.02 -7.23%
52W Low
25.13 51.44%
Volatility
0.47% 1.24%
ATR (14)
1.06
RSI (14)
63.60
Beta
-
Rel Volume
0.08
Avg Volume
1.47K
Volume
14
Perf Week
11.05%
Perf Month
4.92%
Perf Quarter
-
Perf Half Y
-
Perf YTD
49.70%
Perf Year
-
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Prev Close
36.97
Price
38.06
Change %
2.94%
Corgi U.S. Biotech 2x Daily ETF seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the SPDR S&P Biotech ETF. The fund implements its strategy through financial derivatives, resetting exposure on a single-day basis to provide leveraged returns matching a multiple of its reference biotechnology equity universe.